The United States government announced on Friday sanctions against four citizens and a Chinese institution for allegedly participating in “international drug trafficking operations,” particularly fentanyl, a major cause of the opiate crisis in the United States.
The U.S. Department of State and Treasury officials have stated that the victims are Songyan, Zhan Longbao, Cheng Guifeng and Zheng Guangfu, and Global United Biotechnology Inc. because of their alleged relationship with the fentanyl trade.
He said that Global United Biotechnology Inc would be owned by the Zheng Drug Trafficking Organization, headed by Fujing Zheng, and declared an international drug dealer by the Treasury in August 2019.
The State Department said, “This measure is part of the government’s ongoing efforts to end fentanyl and other synthetic opiates that are traded from China and have killed hundreds of thousands of Americans.”
The US government has accused China of being the main source of fentanyl, an opiate that is about 50 times more potent than heroin, and of failing to deliver on its promises to deal with this trafficking that has been refused since Beijing.